Article Sidebar

Submitted
Feb 21, 2020
Published
Nov 30, 2020
Download
Sekar Muktiyani, Nurmainah
Statistic
Read Counter : 814 Download : 702

Downloads

Download data is not yet available.

Main Article Content

Abstract

Depo Medroxyprogesterone Acetate (DMPA) is a method of family planning program. DMPA is preferred because of its economical, practical, and effective in preventing pregnancy. Long-term use DMPA is suspected to be a risk of an increase in blood pressure. The purpose of this study was to analyze the correlation between duration of use with risk of hypertension in the DMPA acceptor at Perumnas II Pontianak Public Health Care. The research method was observational analytic with a retrospective cohort design. The population of the study is the new DMPA acceptor January-June 2018. This period is the index date for the use of DMPA or the date of the first use of DMPA by acceptors. The acceptor is followed by using DMPA for one year or more until the end of the 30 June 2019 study through its medical record data. Samples that met the inclusion and exclusion criteria were 81 acceptors. The results showed that acceptors with a duration of use of DMPA for more than 12 months had more risk of hypertension (66.7%) than acceptors with a duration of use for less than 12 months (38.5%). Chi-square analysis showed a significant correlation between the duration of use of DMPA and the risk of hypertension (p-value = 0.011, RR = 1.733 CI 95% = 1.104 - 2.72 in DMPA acceptor at Perumnas II Pontianak Public Health Care. The study concludes that there is a correlation between duration of use and risk of hypertension.

Keywords

DMPA Duration of use Blood pressure

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

  1. BKKBN. (2013). Profil kependudukan dan pembangunan di Indonesia tahun 2013.
  2. BKKBN. (2018). Survei demografi dan kesehatan Indonesia 2017.
  3. BPS. (2018). Statistik Indonesia 2018.
  4. Dilshad, H., Ismail, R., Naveed, S., Usmanghani, K., Alam, M., & Sarwar, G. (2016). Effect of hormonal contraceptives on seru lipids : A prospective study. Pal. J. Pharm. Sci, 29(4), 1379–1328.
  5. Faiqah, S. (2014). Perbedaan berat badan dan tekanan darah systole ibu sebelum dan sesudah menggunakan kontrasepsi suntik 3 bulan/depo medroksi progesteron asetat (dmpa) di Puskesmas Gerung Lombok Barat. Media Bina Ilmiah 1, 8(1978), 1–7.
  6. Hartanto, H. (2014). Keluarga berencana dan kontrasepsi. Pustaka Sinar Harapan.
  7. Murthy, A., Goldberg, R., & Cardamone, S. (2012). Obesity and contraception: controversy? Open Access Journal of Contraception, January 2012, 1. https://doi.org/10.2147/oajc.s17405
  8. Oktaviary, C., & Wagiyo. (2015). Efek Penggunaan AlatKontrasepsi Pil dan Suntik 3 Bulan Tehadap Status Gizi dan Tekanan darah Pada Akseptor KB Di Puskesmas Kedungmundu Semarang. Jurnal Ilmu Keperawatan Dan Kebidanan.
  9. Oosthuyse, T., & Bosch, A. N. (2012). Oestrogen’s regulation of fat metabolism during exercise and gender specific effects. Current Opinion in Pharmacology, 12(3), 363–371. https://doi.org/10.1016/j.coph.2012.02.008
  10. Riwidikno, & Handoko. (2012). Statistik kesehatan. Mitra Cendikia.
  11. Rotie, N. M., Tombokan, S., & Adam, S. (2015). Hubungan Pengetahuan Dan Tingkat Pendidikan Ibu Dengan Penggunaan Metode Kontrasepsi Efektif Terpilih. Jurnal Ilmiah Bidan, 3(1), 10–14.
  12. Saifuddin, A. (2014). Buku panduan praktis pelayanan kontrasepsi. Yayasan Bina Pustaka Sarwono Prawiroharjdo.
  13. Sanger, O. G., Loho, M. F., & Wirasti, C. R. (2008). Pengaruh suntikan depo medroxy progesteron asetat terhadap profil lipid. 32(3).
  14. Tendean, B., & Hamel, R. S. (2017). Hubungan Penggunaan Alat Kontrasepsi Suntik Depomedroksi Progesteron Asetat (Dmpa) Dengan Tekanan Darah Pada Ibu Di Puskesmas Ranotana Weru. Jurnal Keperawatan, 5(1).
  15. Uswatun Q, Wahyuningsih A, S. S. (2016). Pengaruh lama pemakaian kontraspsi suntik depo medroxy progesteron asetat terhadap peningkatan tekanan darah di BPM Anin Rakhmawati, Sabrang Klaten. Jurnal Involusi Kebidanan, 6(11), 1–12.
  16. Varney. (2010). Manajemen kebidanan. EGC.
  17. Veisi, F., & Zangeneh, M. (2013). Comparison of Two Different Injectable Contraceptive Methods: Depo-medroxy Progesterone Acetate (DMPA) and Cyclofem. Journal of Family & Reproductive Health, 7(3), 109–112. http://www.ncbi.nlm.nih.gov/pubmed/24971112%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4064779
  18. Viola, B. (2013). Pengaruh penggunaan kontrasepsi depo provera terhadap angka kejadian hipertensi di Puskemsas Ngoresan Surakata. Universitas Sebelas Maret.
  19. Wahyuni, E. (2017). Kontrasepsi hormonal progesteron. Penerbit Pustaka Hanif.
  20. Zamané, H., Millogo, G., Ouédraogo, C. M., Sawadogo, Y. A., Nongkouni, E., Kiemtoré, S., Kiemtoré, S., Kaïn, D. P., Kambiré, Y., & Lankoandé, J. (2016). Hormonal Contraception and Hypertension at the Department of Obstetrics and Gynecology, Yalgado Ouédraogo Teaching Hospital: Epidemiological, Clinical and Therapeutic Patterns. Open Journal of Obstetrics and Gynecology, 06(06), 379–384. https://doi.org/10.4236/ojog.2016.66049